MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Describing the syndrome: a comprehensive analysis of a large cohort of corticobasal syndrome with pathological correlation

    D. Vaughan, M. Theilmann Jensen, D. Lux, L. Wu, Z. Jaunmuktane, T. Revesz, T. Lynch, M. Stamelou, K. Seppi, R. Vandenberghe, T. Warner, K. Bhatia, A. Lees, A. Church, N. Leigh, P. Taba, T. Matsalu, P. Mir, B. Ghosh, M. Picillo, J. Wallin, P. Svenningsson, Y. Compta, J. Rohrer, J. Rowe, H. Morris (London, United Kingdom)

    Objective: To describe the clinical, biomarker, genetic and pathological features of a cohort of patients with corticobasal syndrome (CBS). Background: Corticobasal degeneration (CBD) was first…
  • 2023 International Congress

    Piloting the Cats-and-Dogs tool as a culture-fair test for sensory processing impairment in Parkinson’s disease

    D. Mair, K. Dey, E. Camboe, A. Zirra, R. Weil, D. Gallagher, C. Budu, T. Haque, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: This pilot explored the feasibility and culture-fairness of a psychophysical visuoperceptual test for Parkinson’s disease (PD) in a multicultural population in East London. Background:…
  • 2023 International Congress

    Correlation between levels of plasma neurofilament light chain and freezing of gait in Parkinson’s disease

    Y. Zhu, X. Yang, H. Ren, A. Pang (Kunming, China)

    Objective: This study evaluated the correlation between neurofilament light chain (NfL) and freezing of gait (FOG) in Parkinson's disease (PD). Background: PD patients frequently experience…
  • 2023 International Congress

    Protein X: a key player in Parkinson’s Disease pathophysiology? – insights from compound screening in gba1 knock-out medaka

    E. Nakanishi, T. Taguchi, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)

    Objective: This experiment was conducted to elucidate the molecular pathogenesis of Parkinson's disease (PD) and identify potential treatments. Background: PD is one of the most…
  • 2023 International Congress

    TELO2 defect presenting with childhood-onset complex hyperkinetic MD

    M. Novelli, S. Galosi, R. Carrozzo, L. Travaglini, L. Pollini, C. Caputi, F. Pisani, V. Leuzzi (Rome, Italy)

    Objective: Expanding the TELO2-related phenotype by presenting a case with prominent hyperkinetic MD. Background: Telomere maintenance 2 (TELO2), Tel2 interacting protein 2 (TTI2), and Tel2…
  • 2023 International Congress

    MER length as a predictor of motor and non-motor outcomes of STN DBS in Parkinson’s disease

    K. Pillai, S. Joshua, A. Nair, D. Panikar, M. Chacko, A. Thalakkattu, A. Avarachan, H. Prakash, A. Kishore (Kochi, India)

    Objective: To test whether the length of the subthalamic nucleus (STN) in microelectrode recording (MER) can predict the 6-month motor and non-motor outcomes of DBS…
  • 2023 International Congress

    Early-onset spastic ataxia in a patient with prion (PRNP) p.Val180Ile mutation

    SM. Lee, DY. Yoo, TB. Ahn (Seoul, Republic of Korea)

    Objective: To broaden the clinical manifestation of PRNP gene mutation-related ataxia. Background: Genetic forms of prion diseases caused by PRNP mutation account for about 10-15%,…
  • 2023 International Congress

    The effectiveness and usability of online rehabilitation for Parkinson’s Disease patients

    S. Okusa, H. Saegusa, K. Miyakawa, Y. Tsutsumi, S. Ishida, K. Nishikata, T. Nukariya, T. Tezuka, Y. Nihei, Y. Kitagawa, S. Kubo, N. Suzuki, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: The aim was to evaluate the effectiveness and utility of online rehabilitation program by conducting a survey using self-designed questionnaire, Parkinson’s Disease Questionnaire-39 (PDQ-39)…
  • 2023 International Congress

    Safety in Levodopa/carbidopa Intestinal Gel (LCGI) titration in the Intensive Care Unit (ICU) setting for Parkinson’s Disease (PD) patient with severe dysphagia

    N. Lopez Ariztegui, G. Tabar Comellas, MI. Morales Casado, D. Rivero Rodriguez, M. Ennazeh, P. Leal Sanz (Toledo, Spain)

    Objective: Describe a PD patient with obsessive-compulsive disorder (OCD) and paranoid symptoms in whom treatment with LCIG was started in the ICU due to severe…
  • 2023 International Congress

    No laughing white matter: reduced integrity of the lateral nucleus basalis of Meynert pathway in Parkinson’s disease-related cognitive impairment

    R. Crockett, K. Wilkins, S. Aditham, H. Bronte-Stewart (Stanford, USA)

    Objective: Investigate differences in white matter integrity of the nucleus basalis of Meynert (NBM) tracts in Parkinson’s disease (PD) patients who develop mild cognitive impairment…
  • « Previous Page
  • 1
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley